Overall survival among SCT patients with multiple myeloma has improved between 2013 and 2022
This Finnish registry-based study investigated the development of treatment practices and patient outcomes between 2013 and 2022.
Publications
These articles, posters and study abstracts represent a subset of the real world evidence -based and other studies conducted by Medaffcon.
Peer-reviewed articles
Real-world study on patient characteristics, treatment patterns and outcomes for treated patients with chronic lymphocytic leukemia during 2013–2022 in Finland
Ranti J, Jamalzadeh S, Mäkelä E, Vikkula J, Havula E, Luopajärvi S, Lindström V. Annals of Hematology (2025). DOI: 10.1007/s00277-025-06595-5
Nodal peripheral T-cell lymphoma in Finland between 2007 and 2019: Incidence, late morbidity and survival
Partanen A, Rönkä A, Anttalainen A, Ukkola-Vuoti L, Toppila I, Kuitunen H, Miettinen T, Kuittinen, O. British Journal of Haematology (2025). DOI: 10.1111/bjh.20253
A population-based registry study on psoriasis-associated burden of disease in Finland
Ukkola-Vuoti L, Klåvus A, Toppila I, Hällfors J, Veijalainen L, Mälkönen T. Front. Med. (2025). DOI: 10.3389/fmed.2025.1605100
Evolution of treatment practices and outcomes in multiple myeloma during 2013–2022: a Finnish real world registry study
Partanen A, Waltari M, Vikkula J, Mattila R, Närhi K, Eeva J, Putkonen M. Acta Oncologica (2025). DOI: 10.2340/1651-226X.2025.42647
Ruxolitinib treatment outcomes in acute graft-versus-host disease (aGvHD) in a real-world setting in Finland
Martelin E, Kuikka A, Rajal H, Ruohonen T, Mönkkönen H, Vikkula J, Uusi-Rauva K, Salmenniemi U, Itälä-Remes M. Annals of Hematology (2025). DOI: 10.1007/s00277-025-06439-2
Burden of asthma by severity and exacerbation frequency among adult patients naive to biologic asthma therapy: A Finnish cohort study
Kankaanranta H, Viinanen A, Klåvus A, Lassenius MI, Haugom Olsen H, Nieminen K, Lyly A, Kauppi P, Lehtimäki L. Journal of Allergy and Clinical Immunology (2025). DOI: 10.1016/j.jacig.2025.100453
Diabeteksen munuaistaudin toteaminen on puutteellista Keusoten alueella
Laine MK, Haapala M, Uusi-Rauva K, Aakko J, Pentikäinen M, Mikkola K, Halonen N, Pulkki K, Säävuori N, Groop P-H, Metsärinne K. Suom Lääkäril 2025;80:e43390
Population based registry study on large B-cell lymphoma mortality and morbidity in Finland
Anttalainen A, Ukkola-Vuoti L, Vihervaara V, Silvola S, Kuittinen O. Acta Oncologica (2025). DOI: 10.2340/1651-226X.2025.42539
Real-World Observational Study of Incidence and Outcomes in an HR+/HER2- Early Breast Cancer Population with High-Risk of Recurrence in Finland
Singh R, Tuominen S, Lassenius MI, Auvinen M, Torstensson A, Wiklund T. Oncol Ther. (2025). DOI: 10.1007/s40487-024-00324-0
Real-world treatment patterns and survival outcomes in men with metastatic castration-resistant prostate cancer in Finland: a national, population-based cohort study
Rannikko A, Hölsä O, Ågesen T, Ekman M, Mattila R. Acta Oncologica (2025). DOI: 10.2340/1651-226X.2025.42173
Predictors of revision endoscopic sinus surgery in Finnish patients with chronic rhinosinusitis with nasal polyps
Toppila-Salmi S, Lyly A, Simin J, Aakko J, Haugom Olsen H, Lehtimäki L. Clinical and Translational Allergy (2025). DOI: 10.1002/clt2.70032
Increasing incidence and prevalence of Hodgkin’s lymphoma in Finland: a population-based registry study
Antikainen T, Hannuksela N, Anttalainen A, Partanen A, Rönkä A, Kuitunen H, Ukkola-Vuoti L, Toppila I, Miettinen T, Kuittinen O. European Journal of Public Health (2025). DOI: 10.1093/eurpub/ckaf002
A real-world study on the impact of infection load on mortality in multiple myeloma patients in Finland
Anttalainen A, Havula E, Kysenius K, Toppila I, Miettinen T, Lassenius MI, Silvennoinen R, Partanen A, Putkonen M. Annals of Hematology (2024). DOI: 10.1007/s00277-024-06101-3
Real-world results of first-line immunotherapy or targeted therapy for metastatic melanoma in Finland: a cohort study
Mattila K, Tiainen L, Vikkula J, Kreutzman A, Engström M, Kysenius K, Hölsä O, Hernesniemi S, Hemmilä P, Pystynen A, Mäkelä S. Future Oncology (2024). DOI: 10.1080/14796694.2024.2403329
Characteristics, treatment and disease burden among stage 3-4 chronic kidney disease patients with and without type 2 diabetes in Finland during 2016-2022
Metsärinne K, Bodegård J, Toppila I, Uusi-Rauva K, Elmerdahl Frederiksen L, Brinkmann S. NDT (2024). DOI: 10.1093/ndt/gfae242
Prevalence, prognosis, and health care resource utilization in carriers of pathogenic germline variants in BRCA1/2 with incident early-stage breast cancer: a Finnish population-based study
Karihtala P, Laatikainen O, Tuominen S, Ågesen T, Eliasen R. Acta Oncologica (2024). DOI: 10.2340/1651-226X.2024.40829
Attribution of smoking to healthcare costs in the postoperative interval
Gräsbeck H, Reito A, Ekroos H, Aakko J, Hölsä O, Vasankari T. BJS Open (2024). DOI: 10.1093/bjsopen/zrae090
Comorbidities and survival of multiple myeloma patients diagnosed in Finland between 2000 and 2021
Kysenius K, Anttalainen A, Toppila I, Miettinen T, Lassenius MI, Lievonen J, Partanen A, Silvennoinen R, Putkonen M. Annals of Hematology (2024). DOI: 10.1007/s00277-024-05865-y
Survival of patients with classical Hodgkin lymphoma in Finland: a national population-based analysis
Hannuksela N, Partanen A, Anttalainen A, Ukkola-Vuoti L, Toppila I, Vikkula J, Marin K, Kuitunen H, Miettinen T, Kuittinen O, Rönkä A. Blood Cancer Journal (2024). DOI: 10.1038/s41408-024-01125-4
Healthcare Resource Utilisation of Severe Uncontrolled T2low and Non-T2low Asthma in Finland During 2018-2021
Persson J, Aakko J, Kaijala S, Lassenius MI, Viinanen A, Kankaanranta H, Lehtimäki L. Journal of Asthma and Allergy (2024). DOI: 10.2147/JAA.S455911
Treatment and clinical outcomes of patients with acute myeloid leukemia in Finland 2010-2020: A retrospective analysis of electronic health records
Ranti J, Pudas H, Ranta M, Tuominen S, Uusi-Rauva K, Lammela J. European Journal of Haematology (2024) DOI: 10.1111/ejh.14272
Real-World Evidence Study of Patients with KRAS-Mutated NSCLC in Finland
Anttalainen A, Pietarinen P, Tuominen S, Mattila R, Mutka A, Aija Knuuttila. Current Oncology (2024). DOI: 10.3390/curroncol31050205
Trends in clinical characteristics, medication use, and glycemic control in insulin-treated patients with type 1and type 2 diabetes in Finland in 2012–2019: Nationwide real-world evidence study
Niskanen L, Hannula M, Kysenius K, Kaijala S, Lassenius MI, Valle TT. Journal of Diabetes (2024). DOI: 10.1111/1753-0407.13491
Hereditary Angioedema Type 1 and 2 in Finland: Incidence, Prevalence, and Preceding Diagnoses
Sandberg A, Lassenius M, Vihervaara V, Toppila I, Huila L. Acta Dermato-Venereologica (2024). DOI: 10.2340/actadv.v104.24176.
Expenditure and survival of adult patients with intestinal failure due to short bowel syndrome: real-world evidence from Southern Finland
Ukkola-Vuoti L, Tuominen S, Pohju A, Kovac B, Lassenius MI, Merras-Salmio L, Pakarinen MP, Sallinen V, Pikkarainen S. Scand J Gastroenterology (2024). DOI: 10.1080/00365521.2024.2303063
Tofacitinib real-world experience in ulcerative colitis in Finland (FinTofUC): a retrospective non-interventional multicenter patient chart data study
Molander P, Kosunen M, Eronen H, Tillonen J, Käräjämäki A, Heikkinen M, Punkkinen J, Mattila R, Toppila I, Hölsä O, Kalpala K, Henrohn D, Af Björkesten CG. Scand J Gastroenterology (2024). DOI: 10.1080/00365521.2023.2298361
Cyclosporine vs. tacrolimus after liver transplantation for primary sclerosing cholangitis – a propensity score-matched intention-to-treat analysis
Åberg F, Sallinen V, Tuominen S, Adam R, Karam V, Mirza D, Heneghan MA, Line P-D, Bennet W, Ericzon B-G, Grat, M, Lodge P, Rasmussen A, Schmelzle M, Thorburn D, Fondevila C, Helanterä I, Nordin, A. Journal of Hepatology (2023). DOI: 10.1016/j.jhep.2023.08.031
https://www.journal-of-hepatology.eu/article/S0168-8278(23)05100-0/fulltext
Observational study on the evolution of systemic treatments for advanced renal cell carcinoma in Southwest Finland between 2010 and 2021
Hölsä O, Teittinen K, Anttalainen A, Ukkola-Vuoti L, Summanen M, Mattila KE. Therapeutic advances in urology (2023). DOI: 10.1177/17562872231206243
Real-world treatment patterns of Finnish adult patients with atopic dermatitis: From topicals to systemic therapy
Kiiski V, Vikkula J, Ukkola-Vuoti L, Lassenius MI, Kopra J. JEADV Clinical Practice (2023).
DOI: 10.1002/jvc2.247
Real-world evidence on multiple myeloma treated in 2013-2019 in the Hospital District of Helsinki and Uusimaa, Finland
Johanna Vikkula, Kristiina Uusi-Rauva, Tuuli Ranki, Iiro Toppila, Maria Aalto-Setälä, Katariina Pousar, Lotta Vassilev, Kimmo Porkka, Raija Silvennoinen, Oscar Brück. Future Oncology (2023). DOI: 10.2217/fon-2023-0120
Use of Linked Nordic Registries for Population Studies in Hematologic Cancers:
The Case of Multiple Myeloma
Abildgaard N, Freilich J, Anttila P, Bent-Ennakhil N, Ma Y, Lassenius M, Ørstavik S, Toppila I, Waage A, Turesson I, Hansson M. Clinical Epidemiology (2023). DOI: 10.2147/CLEP.S413587
Pediatric short bowel syndrome: real-world evidence on incidence and hospital resource use from a Finnish data lake
Puttonen M, Tuominen S, Ukkola-Vuoti L, Lassenius MI, Virtanen H, Merras-Salmio L, Pakarinen M. Journal of Pediatric Gastroenterology and Nutrition (2023). DOI: 10.1097/MPG.0000000000003894
The Burden of Genital Warts in Finland: Cross-Sectional Analysis of the Prevalence and Direct Medical Costs in 2018
Gylling A, Uusi-Rauva K, Toppila I, Hiltunen-Back E. Vaccines (2023). DOI: 10.3390/vaccines11071202
Type 2 Low Biomarker Stability and Exacerbations in Severe Uncontrolled Asthma
Viinanen A, Aakko J, Lassenius MI, Telg G, Nieminen K, Kaijala S, Lehtimäki L, Kankaanranta H. Biomolecules (2023). DOI: 10.3390/biom13071118
Smoking is a predictor of complications in all types of surgery: a machine learning-based big data study
Gräsbeck H, Reito A, Ekroos H, Aakko J, Hölsä O, Vasankari T. BJS Open (2023). DOI: 10.1093/bjsopen/zrad016
Burden of idiopathic inflammatory rheumatic diseases in occupational healthcare: increased absenteeism and healthcare resource utilization
Ukkola-Vuoti L, Karlsson A, Tuominen S, Lassenius MI, Aaltonen J, Ranta M, Kosunen M, Renlund M, Lehtonen A, Puolakka K. Scan J Work Environ Health (2023). DOI: 10.5271/sjweh.4095
Sydämen vajaatoiminnan ilmaantuvuus ja hoidon kustannukset Suomessa vuosina 2012-2019
Ukkola-Vuoti L, Toppila I, Säävuori N, Kirjavainen A, Ukkonen H, Pentikäinen M. Duodecim (2023) 2023;139(6):455-62.
Effect of Disease Severity on Comorbid Conditions in Atopic Dermatitis: Nationwide Registry-Based Investigation in Finnish Adults
Kiiski V , Ukkola-Vuoti L, Vikkula J, Ranta M, Lassenius MI, Kopra J.
Acta Dermato-Venereologica (2023) Volume 103. DOI: 10.2340/actadv.v103.4447
The burden of chronic rhinosinusitis with nasal polyps and its relation to asthma in Finland
Toppila-Salmi S, Hällfors J, Aakko J, Mannerström B, Nieminen K, Telg G, Lehtimäki L. Clinical and Translational Allergy (2022) Volume 12, Issue 10. DOI: 10.1002/clt2.12200
Comorbidity characteristics of multiple myeloma patients diagnosed in Finland 2005-2016
Toppila I, Kysenius K, Miettinen T, Lassenius MI, Lievonen J, Anttila P. Annals of Hematology (2022) DOI: 10.1007/s00277-022-04959-9
Screening for potential undiagnosed Gaucher disease patients: Utilisation of the Gaucher earlier diagnosis consensus point-scoring system (GED-C PSS) in conjunction with electronic health record data, tissue specimens, and small nucleotide polymorphism (SNP) genotype data available in Finnish biobanks
Pehrsson M, Heikkinen H, Wartivaara-Kautto U, Mäntylahti S, Bäckström P, Lassenius MI, Uusi-Rauva K, Carpén O, Elomaa K. Molecular Genetics and Metabolism Reports (2022) DOI: 10.1016/j.ymgmr.2022.100911
Cardiovascular outcome according to renal status in Finnish patients with type 2 diabetes
Hellman TA, Skare O-L, Lee C, Wagner U, Vikkula J, Hällfors J, Laatikainen O, Lassenius MI, Metsärinne K. Diabetes Epidemiology and Management (2022) DOI: 10.1016/j.deman.2022.100103
Retrospective, Registry-based, Cohort Investigation of Clinical Outcomes in Patients with Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma in Finland
Tuominen S, Ukkola-Vuoti L, Riihilä P, Knuutila JS, Kähäri VM, Lassenius M, Ranki T, Pousar K, Vassilev L, Vuoti S, Mattila K. Acta Derm Venereol (2022) DOI: 10.2340/actadv.v102.2073. PMID: 35356995.
Cardiovascular event rate and death in high-risk secondary prevention patient cohort in Finland: A registry study
Toppila I, Ukkola-Vuoti L, Perttilä J, Törnwall O, Sinisalo J, Hartikainen J, Lehto S. Clinical Cardiology (2022) DOI: 10.1002/clc.23814.
Real-world data on diffuse large B-cell lymphoma in 2010-2019: usability of large data sets of Finnish hospital data lakes
Tuominen S, Uusi-Rauva K, Blom T, Jyrkkiö S, Tuppurainen K, Alanne E. Future Oncology. 2022 Mar;18(9):1103-1114. doi: 10.2217/fon-2021-0806. Epub 2022 Feb 3. PMID: 35109670.
Real-World Clinical Outcomes in Biological Subgroups of Breast Cancer in the Hospital District of Southwest Finland
Teerenhovi H, Tuominen S, Nurmi-Rantala S, Hemmilä P, Ellonen A. The Oncologist (2021) DOI: 10.1002/onco.13813
https://theoncologist.onlinelibrary.wiley.com/doi/epdf/10.1002/onco.13813
The burden of hip and knee osteoarthritis in Finnish occupational healthcare
Summanen M, Ukkola-Vuoti L, Kurki S, Tuominen S, Madanat R. BMC Musculoskelet Disord (2021) DOI: 29;22(1):501.
https://bmcmusculoskeletdisord.biomedcentral.com/track/pdf/10.1186/s12891-021-04372-9.pdf
Characteristics and survival trends in Finnish multiple myeloma patients – a nationwide real-world evidence study
Toppila I, Miettinen T, Lassenius MI, Lievonen J, Bauer M, Anttila P. Ann Hematol (2021). DOI: 10.1007/s00277-021-04481-4.
The Gaucher earlier diagnosis consensus point-scoring system (GED-C PSS): Evaluation of a prototype in Finnish Gaucher disease patients and feasibility of screening retrospective electronic health record data for the recognition of potential undiagnosed patients in Finland
Savolainen MJ, Karlsson A, Rohkimainen S, Toppila I, Lassenius MI, Vaca Falconi C, Uusi-Rauva K ja Elomaa K. Molecular Genetics and Metabolism Reports (2021) DOI: 10.1016/j.ymgmr.2021.100725.
My Migraine Voice survey: disease impact on healthcare resource utilization, personal and working life in Finland
Sumelahti M-J, Sumanen M, Sumanen MS, Tuominen S, Vikkula J, Honkala SM, Rosqvist S ja Korolainen MA. The Journal of Headache and Pain (2020) DOI: 10.1186/s10194-020-01185-4.
https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-020-01185-4
Recurrent hospitalizations are associated with increased mortality across the ejection fraction range in heart failure
Huusko J, Tuominen S, Studer R, Corda S, Proudfoot C, Lassenius MI ja Ukkonen H. ESC Heart Failure (2020) DOI: 10.1002/ehf2.12792.
Real-world clinical diagnostics of heart failure patients with reduced or preserved ejection fraction
Huusko J, Purmonen T, Toppila I, Lassenius M ja Ukkonen H. ESC Heart Failure (2020) DOI: 10.1002/ehf2.12665.
Cardiovascular event rates increase after each recurrence and associate with poor statin adherence
Lassenius MI, Toppila I, Bergius S, Perttilä J, Airaksinen KEJ ja Pietilä M. European Journal of Preventive Cardiology (2020) DOI: 10.1177/2047487320904334.
Burden of migraine in Finland: multimorbidity and phenotypic disease networks in occupational healthcare
Korolainen MA, Tuominen S, Kurki S, Lassenius MI, Toppila I, Purmonen T, Santaholma J ja Nissilä M. The Journal of Headache and Pain (2020) 21:8. DOI: 10.1186/s10194-020-1077-x.
https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-020-1077-x
Forced Vital Capacity (FVC) decline, mortality and healthcare resource utilization in idiopathic pulmonary fibrosis
Lassenius MI, Toppila I, Pöntynen N, Kasslin L, Kaunisto J, Kilpeläinen M ja Laitinen T. European Clinical Respiratory Journal (2019) 7:1, 1702618, DOI: 10.1080/20018525.2019.1702618.
https://www.tandfonline.com/doi/full/10.1080/20018525.2019.1702618
The Burden Of Chronic Obstructive Pulmonary Disease (COPD) In Finland: Impact Of Disease Severity And Eosinophil Count On Healthcare Resource Utilization
Viinanen A, Lassenius MI, Toppila I, Karlsson A, Veijalainen L, Idänpään-Heikkilä JJ ja Laitinen T. International Journal of Chronic Obstructive Pulmonary Disease (2019) 14:2409-2421.
The burden of adult asthma in Finland: impact of disease severity and eosinophil count on health care resource utilization
Viinanen A, Lassenius M, Toppila I, Karlsson A, Veijalainen L, Idänpään-Heikkilä J ja Laitinen T. Journal of Asthma (2019). DOI: 10.1080/02770903.2019.1633664.
https://www.tandfonline.com/doi/full/10.1080/02770903.2019.1633664
Heart failure in Finland: clinical characteristics, mortality, and healthcare resource use
Huusko J, Kurki S, Toppila I, Purmoen T, Lassenius M, Gullberg E, Bruce-Wirta S ja Ukkonen H. ESC Heart Failure (2019). DOI: 10.1002/ehf2.12443.
Burden of migraine in Finland: health care resource use, sick-leaves and comorbidities in occupational health care
Korolainen M, Kurki S, Lassenius M, Toppila I, Costa-Scharplatz M, Purmonen T ja Nissilä M. Journal of headache and pain (2019) 20:13. DOI: 10.1186/s10194-019-0964-5.
Type 2 diabetes and treatment intensification in primary care in Finland
Niskanen L, Hahl J, Haukka J, Leppä E, Miettinen T, Mushnikov V, Sipilä R, Tamminen N, Vattulainen P ja Korhonen P. Acta Diabetologica (2018) 55:1171-1179.
Health care resource utilization and characteristics of patients with eosinophilic asthma in secondary health care in Finland
Mäkelä MJ, Christensen HN, Karlsson A, Rastogi S ja Kettunen K. European Clinical Respiratory Journal (2018) 5(1):1458560.
Re-treatment with varenicline is a cost-effective aid for smoking cessation
Kautiainen K, Ekroos H, Puhakka M, Liira H, Laine J, Linden K, Hahl J. J Med Econ. 2017 Mar;20(3):246-252. DOI: 10.1080/13696998.2016.1249485.
Burden of illness in multiple sclerosis (DEFENSE) study: the costs and quality-of-life of Finnish patients with multiple sclerosis
Ruutiainen J, Viita A-M, Hahl J, Sundell J, Nissinen H. J Med Econ 2016;19(1):21-33. DOI: 10.3111/13696998.2015.1086362.
Posters or oral presentations at international congresses
Visualization of the impact of rotavirus vaccination in Finland
Toppila i, et al. 43rd Annual Meeting of European Society for Paediatric Infectious Diseases; May 26-30, 2025; Bucharest, Romania.
Machine Learning-Based Prediction of Survival Prognosis for Treated NSCLC Patients: Insights from Finnish Real-World Data
Koistinen V, Ekroos H, Mattila R, Jamalzadeh S, Hölsä O, Knuuttila A. ELCC 2025 Paris, France.
Real-World Evidence Study of Patients With NSCLC in Finland: Use of Machine Learning Algorithm to Extract Smoking Status From Patient Texts and Analysis of Resource Use and Survival by Smoking Status
Ekroos H, Koistinen V, Hölsä O, Mattila R, Knuuttila A. ISPOR Europe 2024, Barcelona, Spain.
https://www.ispor.org/heor-resources/presentations-database/presentation/euro2024-4016/144548
Real – world observations on the evolving treatment landscape and improved survival outcomes for myeloma patients in Finland
Partanen A, Vikkula J, Waltari M, Mattila R, Närhi K, Eeva J, Putkonen M. EHA 2024, June 13-16, Madrid, Spain.
Prevalence, risks and treatment of incident chronic kidney disease stage 3-4: an observational study in Finland between 2016-2022
Metsärinne K, Toppila I, Uusi-Rauva K, Elmerdahl Frederiksen L, Bodegård J, Brinkmann S. ERA Congress, Stockholm, Sweden, 2024. Nephrology Dialysis Transplantation, Volume 39, Issue Supplement_1, May 2024
Ruxolitinib treatment outcomes in acute graft-versus-host disease (aGvHD) in real-world setting in Finland
Martelin E, Kuikka A, Rajala H, Ruohonen T, Mönkkönen H, Vikkula J, Uusi-Rauva K, Salmenniemi U, Itälä-Remes M. 50th Annual Meeting of the EBMT, Glasgow, UK, 2024. Bone Marrow Transplant 59 (Suppl 1), 140–665, 2024
Patient Characteristics and Treatment Patterns in Patients with Advanced Psoriasis in Specialty Care Settings in Finland
Koulu L, Passero L, Zhong Y, Alanen S, Uusi-Rauva K, Tuominen S, Sainio T. ISPOR Europe, Copenhagen, Denmark, 2023. Value in Health, Volume 26, Issue 12, S312
Healthcare Resource Use and Cost in Metastatic Castration Resistant Prostate Cancer (mCRPC) in Finland
Rannikko A, Ågesen T, Hölsä O, Tuominen S, Ekman M, Mattila R. ISPOR Europe, Copenhagen, Denmark, 2023
Incidence, prevalence and characteristics of patients with chronic kidney disease in primary care in Finland
Metsärinne K, Kaijala S, Mannerström B, Elmerdahl Frederiksen L, Brinkmann S. 37th Biennial Congress of the Nordic Society of Nephrology, Reykjavik, Iceland, 2023
Economic burden of genital warts in Finland in 2018
Gylling, A., Uusi-Rauva, K., Toppila, I., Hiltunen-Back, E. EUROGIN 2023, Bilbao, Spain, 2023.
Patient characteristic, treatment and outcomes in metastatic castration resistant prostate cancer (mCRPC) in Finland
Rannikko A, Ågesen T, Hölsä O, Tuominen S, Hanssen J, Mattila R. European Association of Urology Congress 2023 (EAU23), Milan, Italy, 10-13 March 2023.
The burden of R/R DLBCL in Finland: PFS of the first-line immunochemotherapy and HCRU of the patients diagnosed in 2015–2017 in the Hospital District of Southwest Finland
Koski L, Tuominen S, Uusi-Rauva K, Blom T, Tuppurainen K, Alanne E. ISPOR Europe, Vienna, Austria, 2022.
Validation of the GED-C point-scoring system in true Gaucher disease patients
Savolainen M, Karlsson A, Uusi-Rauva K, Lassenius MI, Elomaa K, Falconi CV, Rohkimainen S. 16th Annual World symposium, Orlando, USA, 2020.
The real-world dose differences of insulin glargine 300 U/ml in Finland
Koski L, Hahl J, Kaye S & Pousar K. ISPOR Europe, Nov 2019, Copenhagen, Denmark.
https://www.ispor.org/heor-resources/presentations-database/presentation/euro2019-3120/94970
Migraine comorbidity and phenotypic disease networks in occupational health care
Korolainen M A, Kurki S, Tuominen S, Toppila I, Lassenius M I, Santaholma J, Purmonen T, Nissilä M. 19th Congress of the International Headache Society, Sep 7-8, 2019; Dublin, Ireland.
Study to determine predictive potential of an algorithm for earlier diagnosis of Gaucher disease: Retrospective biobank study utilizing real-world data available in Finland
Savolainen M, Karlsson A, Toppila I, Elomaa K, Panahloo Z, Wolf M. 15th Annual WORLD Symposium, Feb 4-8, 2019; Orlando, Florida, USA.
Health Registry Data Survey for Assessing Characteristics and Descriptive Epidemiology of Patients with Multiple Myeloma in Southwest Finland between 2004—May 2017
Salmi T, Saukkonen K, Wolf, M, Toppila I, Kurki S, Schoonen M, Putkonen M. ESH, 4th International Conference on multiple myeloma, Oct 5-7, 2018; Mandelieu, France.
Health care resource use, sick-leaves and comorbidities among migraine patients in occupational healthcare
Korolainen M A, Kurki S, Toppila I, Lassenius M, Purmonen T, Nissilä M. European Headache federation meeting, Sep 28-30, 2018; Florence, Italy.
Heart Failure in Finland – Evaluating the burden of disease and treatment patterns
Huusko J, Kurki S, Toppila I, Purmonen T, Lassenius M, Gullberg E, Bruce-Wirta S, Ukkonen H. European Society of Cardiology Congress, 2018; Munich, Germany.
Trend towards longer time to reimbursement in oncological medicines in Finland 2005-2015
Oinonen L, Renlund M, Pudas H, Ihalmo P, Hahl J. ISPOR, 2016.
The epidemiology of adult immune (idiopathic) thrombocytopenic purpura (ITP) in Finland: resource utilisation, related costs and hospital medication associated with the treatment of non-splenectomised adult ITP based on real world data from Auria biobank
Kosunen M, Kurki S, Snicker K, Wiik E. ISPOR, 2017.
Resource utilisation and related health care costs among patients with multiple myeloma with ≥ 2 prior lines of treatment in Finland: evaluation based on Finnish real world data from Auria biobank
Kosunen M, Kurki S, Snicker K, Wiik E. ISPOR, 2017.
Resource use, health care costs and burden of disease in patients with polycythemia vera in Finland: evaluation based on leukocyte counts using Finnish real world data from Auria biobank
Kosunen M, Kurki S, Snicker K, Wiik E. ISPOR, 2017.
Cost-effectiveness of Pasireotide long-acting in a treatment of acromegaly in Finland. Economic evaluation based on Finnish Auria biobank data on health care resource utilization
Hahl J, Kurki S, Miettinen T, Snicker K. ISPOR, 2015.
Other
Lääkkeiden riskinjakosopimukset Suomen sairaaloissa – kyselytutkimus 2019
Honkanen H, Snicker K ja Ahlamaa J. Suomen Lääkärilehti 2019; 49:2872 – 2876.
Tutkimuksen uudet mahdollisuudet on huomioitava biopankkilaissa
Tuompo W, Hemmilä P, Ahlamaa J ja Wolf M. Finnish Medical Journal (2018) 37: 2006-2007.
Read summaries of our RWE studies
-
-
Asthma and Antibiotic Use Increase the Risk of Revision Surgery in CRSwNP Patients
Asthma and antibiotic use are linked to a higher risk of revision surgery in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). This finding is based on a real-world evidence (RWE) study published in February.
-
Prostate Cancer Study Successfully Linked Deep Clinical Hospital Data with Broader Healthcare Data
A real-world evidence (RWE) study on the treatment of metastatic castration-resistant prostate cancer (mCRPC) has provided new insights into the therapeutic strategies for mCRPC. The analysis was based on data from 2,500 patients treated in Finland.